290 related articles for article (PubMed ID: 21792920)
21. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration.
Yu J; Moon A; Kim HR
Biochem Biophys Res Commun; 2001 Apr; 282(3):697-700. PubMed ID: 11401517
[TBL] [Abstract][Full Text] [Related]
22. Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells.
Wang R; Qi B; Dong YW; Cai QQ; Deng NH; Chen Q; Li C; Jin YT; Wu XZ
Oncotarget; 2016 Jun; 7(24):36563-36576. PubMed ID: 27145276
[TBL] [Abstract][Full Text] [Related]
23. Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats.
Rani UP; Kesavan R; Ganugula R; Avaneesh T; Kumar UP; Reddy GB; Dixit M
J Nutr Biochem; 2013 Nov; 24(11):1830-9. PubMed ID: 23866995
[TBL] [Abstract][Full Text] [Related]
24. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells.
Jin S; Hansson EM; Tikka S; Lanner F; Sahlgren C; Farnebo F; Baumann M; Kalimo H; Lendahl U
Circ Res; 2008 Jun; 102(12):1483-91. PubMed ID: 18483410
[TBL] [Abstract][Full Text] [Related]
25. Convergence of physical and chemical signaling in the modulation of vascular smooth muscle cell cycle and proliferation by fibrillar collagen-regulated P66Shc.
Yeh YT; Lee CI; Lim SH; Chen LJ; Wang WL; Chuang YJ; Chiu JJ
Biomaterials; 2012 Oct; 33(28):6728-38. PubMed ID: 22770800
[TBL] [Abstract][Full Text] [Related]
26. Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.
Sachinidis A; Seul C; Gouni-Berthold I; Seewald S; Ko Y; Vetter H; Fingerle J; Hoppe J
Br J Pharmacol; 2000 Aug; 130(7):1561-70. PubMed ID: 10928958
[TBL] [Abstract][Full Text] [Related]
27. TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC.
Siegbahn A; Johnell M; Nordin A; Aberg M; Velling T
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):135-41. PubMed ID: 17991872
[TBL] [Abstract][Full Text] [Related]
28. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
[TBL] [Abstract][Full Text] [Related]
29. Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation.
Son JE; Lee E; Jung SK; Kim JE; Oak MH; Lee KW; Lee HJ
Cardiovasc Res; 2014 Mar; 101(3):503-12. PubMed ID: 24363205
[TBL] [Abstract][Full Text] [Related]
30. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.
ten Freyhaus H; Huntgeburth M; Wingler K; Schnitker J; Bäumer AT; Vantler M; Bekhite MM; Wartenberg M; Sauer H; Rosenkranz S
Cardiovasc Res; 2006 Jul; 71(2):331-41. PubMed ID: 16545786
[TBL] [Abstract][Full Text] [Related]
31. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
[TBL] [Abstract][Full Text] [Related]
32. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.
Nagaharu K; Zhang X; Yoshida T; Katoh D; Hanamura N; Kozuka Y; Ogawa T; Shiraishi T; Imanaka-Yoshida K
Am J Pathol; 2011 Feb; 178(2):754-63. PubMed ID: 21281808
[TBL] [Abstract][Full Text] [Related]
33. Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1.
Kamimura M; Bea F; Akizawa T; Katus HA; Kreuzer J; Viedt C
Hypertension; 2004 Dec; 44(6):944-51. PubMed ID: 15492129
[TBL] [Abstract][Full Text] [Related]
34. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
[TBL] [Abstract][Full Text] [Related]
35. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells.
Lucero HA; Ravid K; Grimsby JL; Rich CB; DiCamillo SJ; Mäki JM; Myllyharju J; Kagan HM
J Biol Chem; 2008 Aug; 283(35):24103-17. PubMed ID: 18586678
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of platelet-derived growth factor receptor-β signaling mediated by integrin-associated MFG-E8.
Motegi S; Garfield S; Feng X; Sárdy M; Udey MC
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2653-64. PubMed ID: 21868707
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
Blaschke F; Stawowy P; Kappert K; Goetze S; Kintscher U; Wollert-Wulf B; Fleck E; Graf K
Basic Res Cardiol; 2002 Jul; 97(4):334-42. PubMed ID: 12111044
[TBL] [Abstract][Full Text] [Related]
38. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF.
Chen CP; Hung CF; Lee SC; Lo HM; Wu PH; Wu WB
Naunyn Schmiedebergs Arch Pharmacol; 2010 May; 381(5):401-14. PubMed ID: 20237770
[TBL] [Abstract][Full Text] [Related]
39. Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling.
Stehr M; Adam RM; Khoury J; Zhuang L; Solomon KR; Peters CA; Freeman MR
J Urol; 2003 Mar; 169(3):1165-70. PubMed ID: 12576874
[TBL] [Abstract][Full Text] [Related]
40. Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery.
Ishii S; Okamoto Y; Katsumata H; Egawa S; Yamanaka D; Fukushima M; Minami S
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):359-66. PubMed ID: 23324994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
